St. Louis encephalitis Activators
St. Louis encephalitis Activators are a class of chemicals that have the capacity to directly or indirectly enhance the functional activity of St. Louis encephalitis (SLE), a flavivirus responsible for encephalitis in humans. These activators operate by modifying the biochemical microenvironment to favor SLE's lifecycle stages, which include viral entry, uncoating, replication, assembly, and exit from the host cell. For instance, Chloroquine and Amantadine enhance SLE's capacity to penetrate the host cell and uncoat its genome by respectively altering the endosomal pH and inhibiting viral protein functions. On the other hand, 5-fluorouracil increases SLE's adaptability and fitness by enhancing its mutation rate, therefore leading to a more efficient replication cycle.
Azithromycin and Cyclosporin A, and Rapamycin create a cellular environment that is more conducive to SLE replication. They achieve this by modulating cellular processes such as nucleotide metabolism, inflammation, immune response, and autophagy. Additionally, Statins, by affecting cholesterol metabolism in the host cell membrane, can enhance the assembly and release of SLE. Finally, Sorafenib, Sunitinib, and Gefitinib can enhance SLE's replication cycle by altering cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is an antimalarial drug that can also alter endosomal pH. St. Louis encephalitis (SLE) utilizes endosomes for entry into the cell, and alterations in pH by Chloroquine can enhance the virus's ability to penetrate the cell membrane and begin replication. | ||||||
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
Amantadine is an antiviral drug that inhibits viral protein (M2) functions. M2 proteins are essential for viral uncoating, and inhibition by Amantadine can enhance the entry and uncoating process of SLE, leading to enhanced viral replication. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
Azithromycin is an antibiotic known for its anti-inflammatory and immunomodulatory effects. It can suppress production of pro-inflammatory cytokines, which can lead to an environment more favorable for SLE replication. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that can inhibit several tyrosine protein kinases. Inhibition of these kinases can lead to changes in cellular signaling that favor viral replication processes, potentially enhancing SLE's replication cycle. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $197.00 $520.00 $1093.00 | 4 | |
Sunitinib is a tyrosine kinase inhibitor that can alter cellular signaling pathways. Changes in these pathways can create a cellular environment favoring viral replication, potentially enhancing SLE's replication cycle. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-fluorouracil is a pyrimidine analog that can be incorporated into viral RNA, leading to an increased mutation rate. Enhanced mutation rates can increase the adaptability and fitness of SLE, potentially leading to a more efficient replication cycle. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A is an immunosuppressive drug that can inhibit calcineurin, leading to the inhibition of transcription of IL-2. The suppression of the immune response can create a more favorable environment for SLE replication. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can alter cellular metabolism and autophagy. Changes in these cellular processes can create a more favorable environment for SLE replication. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR inhibitor that can alter cellular signaling pathways. Changes in these pathways can create a cellular environment favoring viral replication, potentially enhancing SLE's replication cycle. | ||||||